Erzofri (paliperidone palmitate)
Summary
BCBS Mississippi has added a new policy declaring Erzofri (paliperidone palmitate) injections as not medically necessary for schizophrenia and schizoaffective disorder treatment due to availability of covered alternatives. All services related to this medication will be denied without prior authorization approval.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.